NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AudioCure Pharma

AudioCure Pharma

Private
BerlinHealthcare & Life Scienceshttps://www.audiocure.com/

Last Round

VC Round

Feb 13, 2025

Total Funding Raised

$9.54M

Company Overview

AudioCure Pharma is a biotechnology company that develops novel pharmaceutical therapies for the treatment of hearing impairments and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyhearing loss treatmenttinnitus therapysmall-molecule therapeuticsclinical-stage biotechdrug discoveryinner ear regenerationsensorineural hearing lossclinical trialshearing loss curehair cell regenerationpharma R&Dotology researchhearing loss startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AudioCure Pharma Comparables

Compare AudioCure Pharma with similar companies based on industry and business-model similarity.

AudioCure Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acousia Therapeutics GmbH
93%
Strekin AG
88%
Sound Pharmaceuticals, Inc.
86%

AudioCure Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 13, 2025
Series ANov 29, 2016
SeedMay 29, 2012

Key People

Founding team and executive leadership

Reimar Schlingensiepen

CEO

Executive Team

AudioCure Pharma Investors

Notable investors and investment history

AudioCure Pharma investors
InvestorRounds
High-Tech GründerfondsSeed, Series A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Monthly visitors increased 115% MoM.

  • May 2, 2025

    Monthly visitors increased 1300% MoM, reaching 2.1K.

AudioCure Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AudioCure Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AudioCure Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range16
Year Founded2012
Last FundingFeb 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.